The U.S. Cybersecurity and Infrastructure Security Agency (CISA) on Wednesday added a critical security flaw impacting Motex ...
The age of hybrid work is here. 76% of companies say they have shifted to a hybrid work strategy, splitting work hours between an office and remote environment. Only 11% of teams say they’re planning ...
Motex released urgent patches for a critical vulnerability in Lanscope Endpoint Manager that has been exploited in the wild as a zero-day.
MSK played a central role in the U.S. Food and Drug Administration (FDA) Oncologic Drugs Advisory Committee (ODAC)’s landmark decision in April 2024 to accept measurable residual disease (MRD) as an ...
About 15 years ago, Carl Ola Landgren, M.D. Ph.D., noticed an encouraging yet potentially concerning trend in the treatment of multiple myeloma. Drugs had become so increasingly efficacious that they ...
Novartis (NVS) today announced that Cosentyx met the primary endpoint and all secondary endpoints in the Phase III REPLENISH trial. Cosentyx ...
Moderna said its cytomegalovirus (CMV) vaccine didn't meet the primary efficacy endpoint in a Phase 3 trial, and it is discontinuing the clinical development program.
Shares of Neuphoria Therapeutics were trading in the red in the after-hours session Monday, as the company announced a strategic review following news BNC210 anti-anxiety drug didn't meet the primary ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback